Log in to save to my catalogue

Alpha-synuclein research: defining strategic moves in the battle against Parkinson’s disease

Alpha-synuclein research: defining strategic moves in the battle against Parkinson’s disease

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_78fcd2512d1c4506897e5895f2a201f4

Alpha-synuclein research: defining strategic moves in the battle against Parkinson’s disease

About this item

Full title

Alpha-synuclein research: defining strategic moves in the battle against Parkinson’s disease

Publisher

London: Nature Publishing Group UK

Journal title

NPJ Parkinson's Disease, 2021-07, Vol.7 (1), p.65-65, Article 65

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

With the advent of the genetic era in Parkinson’s disease (PD) research in 1997, α-synuclein was identified as an important player in a complex neurodegenerative disease that affects >10 million people worldwide. PD has been estimated to have an economic impact of $51.9 billion in the US alone. Since the initial association with PD, hundreds of res...

Alternative Titles

Full title

Alpha-synuclein research: defining strategic moves in the battle against Parkinson’s disease

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_78fcd2512d1c4506897e5895f2a201f4

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_78fcd2512d1c4506897e5895f2a201f4

Other Identifiers

ISSN

2373-8057

E-ISSN

2373-8057

DOI

10.1038/s41531-021-00203-9

How to access this item